- Price
- $39.67
- Day
- -0.78%
- Mkt Cap
- $26.13B
- 52W Range
- $37.13 – $45.26
- Volume
- 4.07M
- Beta
- 0.45
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Beacon Pointe Advisors LLC acquired a new position in shares of CenterPoint Energy, Inc. (NYSE: CNP) in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 13,763 shares of the utilities provider's stock, valued at approximately $606,000. A number of other hedge
Read full article
BioMarin Announces Global Settlement with Ascendis Pharma A/S; Ascendis Will Pay Royalties to BioMarin on Yuviwel Sales in U.S., EU, Brazil and
Read full article
To help keep its customers and communities safe ahead of the Invest 97L weather system, CenterPoint is actively monitoring evolving weather conditions, preparing frontline personnel to respond to potential impacts on system and closely coordinating with local officials The system has the potential for gusty winds, several inches of heavy rainfall and localized flooding in parts of the Greater Houston region starting Tuesday HOUSTON, Aug. 31, 2026 /PRNewswire/ -- To support its customers and communities, CenterPoint Energy is activating its Emergency Operations Center this morning and is actively monitoring and preparing for potential impacts from Invest 97L to Southeast Texas, including Greater Houston, starting Tuesday. The system could bring several inches of heavy rainfall, localized flooding and the potential for gusty winds to the company's service territory.
Read full article
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does CenterPoint (CNP) have what it takes?
Read full article
CenterPoint (CNP) reported earnings 30 days ago. What's next for the stock?
Read full article
The most oversold stocks in the utilities sector presents an opportunity to buy into undervalued companies.
Read full article
COPENHAGEN, Denmark, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that its participation at ISDS 2026, the annual meeting of the International Skeletal Dysplasia Society being held in Toronto, Canada, from August 26-29, 2026, will include an oral presentation of Week 104 data from its pivotal ApproaCH Trial of once-weekly TransCon CNP (navepegritide) in children with achondroplasia. The presentation will be given by Carlos Bacino, M.D., FACMG, Professor of Molecular and Human Genetics, Baylor College of Medicine and Texas Children's Hospital.
Read full article
Barrow Hanley Mewhinney and Strauss LLC bought a new position in CenterPoint Energy, Inc. (NYSE: CNP) in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 3,420,488 shares of the utilities provider's stock, valued at approximately $150,638,000. Barrow Hanley Mewhinney and
Read full article
The executive disposed of 17,075 shares valued at $686,000 based on the August 11, 2026 weighted average sale price.. This transaction represents a 9% reduction in the executive's direct equity holdings.
Read full article